Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study

INTRODUCTION: Primary aim was to provide real-world evidence of the outcomes after the switch to glargine 300 U/ml (Gla-300) from other basal insulins (first or second generation) in Italy. METHODS: Multicenter, observational, retrospective study based on electronic medical records. RESULTS: Overall...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes Ther
Glavni autori: Ragonese, Mauro, Larosa, Monica, Angotti, Stefania, Annese, Stefania, Cruciani, Laura, Dainelli, Michela, Lucisano, Giuseppe, Prosperini, Giuseppe, Sacco, Michele, Salomone, Enrica, Saponara, Caterina, Semprini, Roberta, Rossi, Maria Chiara, Nicolucci, Antonio
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509008/
https://ncbi.nlm.nih.gov/pubmed/32813262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00902-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items